Best TWAS P=2.51e-11 · Best GWAS P=3.28e-12 conditioned to 4.02e-10
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | CommonMind | Brain Pre-frontal Cortex | UBXN2A | 0.22 | 0.18 | enet | 28 | 0.24 | 3.0e-28 | 6.1 | -6.0 | 1.6e-09 | 0.05 | 0.03 | 0.97 | FALSE |
2 | GTEx | Cells EBV-transformed lymphocytes | PFN4 | 0.18 | 0.13 | lasso | 12 | 0.12 | 8.9e-05 | 3.9 | 5.3 | 1.1e-07 | -0.03 | 0.09 | 0.73 | FALSE |
3 | GTEx | Cells EBV-transformed lymphocytes | RP11-443B20.1 | 0.13 | 0.13 | enet | 9 | 0.05 | 9.2e-03 | -5.0 | 5.5 | 4.5e-08 | 0.05 | 0.31 | 0.17 | FALSE |
4 | GTEx | Esophagus Gastroesophageal Junction | PFN4 | 0.13 | 0.01 | lasso | 12 | 0.01 | 9.7e-02 | 6.4 | 5.8 | 8.5e-09 | -0.06 | 0.07 | 0.42 | FALSE |
5 | GTEx | Heart Atrial Appendage | UBXN2A | 0.08 | 0.02 | lasso | 3 | 0.02 | 5.2e-02 | 6.7 | 6.7 | 2.9e-11 | -0.04 | 0.02 | 0.94 | FALSE |
6 | GTEx | Heart Atrial Appendage | PFN4 | 0.22 | 0.06 | lasso | 7 | 0.10 | 2.8e-05 | -2.2 | 5.3 | 1.2e-07 | -0.05 | 0.10 | 0.86 | FALSE |
7 | GTEx | Nerve Tibial | ADCY3 | 0.09 | 0.05 | enet | 6 | 0.03 | 2.2e-03 | -3.9 | 5.4 | 7.8e-08 | 0.01 | 0.85 | 0.12 | FALSE |
8 | METSIM | Adipose | POMC | 0.18 | 0.06 | lasso | 9 | 0.09 | 5.5e-13 | 2.9 | 5.1 | 2.7e-07 | -0.09 | 0.97 | 0.03 | FALSE |
9 | METSIM | Adipose | UBXN2A | 0.07 | 0.03 | bslmm | 403 | 0.06 | 5.3e-10 | 3.9 | 5.2 | 1.7e-07 | -0.02 | 0.17 | 0.83 | FALSE |
10 | ROSMAP | Brain Pre-frontal Cortex | UBXN2A | 0.03 | 0.01 | lasso | 4 | 0.02 | 2.2e-03 | 6.7 | -6.6 | 4.9e-11 | 0.07 | 0.02 | 0.95 | FALSE |
11 | YFS | Blood | POMC | 0.35 | 0.05 | enet | 71 | 0.19 | 5.7e-59 | 7.0 | 6.6 | 5.1e-11 | -0.06 | 0.00 | 1.00 | TRUE |
12 | The Cancer Genome Atlas | Breast Invasive Carcinoma | POMC | 0.08 | 0.05 | lasso | 3 | 0.06 | 2.6e-12 | 3.2 | 5.5 | 4.9e-08 | -0.05 | 0.63 | 0.37 | FALSE |
13 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | EFR3B | 0.03 | 0.05 | lasso | 1 | 0.04 | 1.9e-05 | 5.2 | 5.2 | 1.7e-07 | 0.02 | 0.09 | 0.85 | FALSE |
14 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | POMC | 0.16 | 0.05 | blup | 39 | 0.11 | 2.4e-12 | 7.0 | 6.2 | 7.5e-10 | -0.07 | 0.00 | 1.00 | FALSE |
15 | The Cancer Genome Atlas | Brain Lower Grade Glioma | UBXN2A | 0.04 | 0.04 | lasso | 1 | 0.03 | 1.4e-04 | 6.7 | -6.7 | 2.5e-11 | 0.05 | 0.01 | 0.98 | TRUE |
16 | The Cancer Genome Atlas | Lung Adenocarcinoma | POMC | 0.14 | 0.04 | enet | 7 | 0.08 | 5.3e-10 | 3.2 | 5.4 | 5.6e-08 | -0.08 | 0.10 | 0.89 | FALSE |
17 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | POMC | 0.19 | 0.01 | blup | 38 | 0.05 | 1.5e-04 | 7.0 | 6.2 | 4.3e-10 | -0.07 | 0.00 | 0.85 | FALSE |
18 | The Cancer Genome Atlas | Prostate Adenocarcinoma | POMC | 0.11 | 0.08 | enet | 7 | 0.09 | 1.6e-09 | 3.2 | 6.0 | 2.7e-09 | -0.06 | 0.13 | 0.87 | FALSE |
19 | The Cancer Genome Atlas | Stomach Adenocarcinoma | POMC | 0.14 | 0.00 | blup | 40 | 0.02 | 2.2e-02 | 3.6 | 5.8 | 8.6e-09 | -0.04 | 0.00 | 0.62 | FALSE |